Literature DB >> 27171917

EPIRETINAL MEMBRANE FORMATION AFTER INTRAVITREAL AUTOLOGOUS STEM CELL IMPLANTATION IN A RETINITIS PIGMENTOSA PATIENT.

Ju Young Kim1, Yong Sung You, Soon Hyun Kim, Oh Woong Kwon.   

Abstract

METHODS: A retrospective case report of a retinitis pigmentosa patient who underwent vitrectomy for epiretinal membrane after intravitreal autologous stem cell implantation.
RESULTS: A 71-year-old female RP patient came to our clinic for ophthalmic evaluation after intravitreal autologous stem cell injection. Four months ago, she underwent intravitreal autologous stem cell injection for both eyes at another hospital. New thick epiretinal membrane (ERM) with extensive macular pucker was found on her left eye. She underwent pars plana vitrectomy and membranectomy. After biopsy, many CD34-positive stem cells were detected in ERM specimen.
CONCLUSION: This is the first report of ERM formation following intravitreal autologous stem cells injection. CD34-positive stem cells were detected in a human eye at 4 months after injection. Further studies are needed to determine how stem cells caused ERM and how long they would stay in the eye.

Entities:  

Mesh:

Year:  2017        PMID: 27171917     DOI: 10.1097/ICB.0000000000000327

Source DB:  PubMed          Journal:  Retin Cases Brief Rep        ISSN: 1935-1089


  11 in total

Review 1.  Protecting retinal ganglion cells.

Authors:  T Z Khatib; K R Martin
Journal:  Eye (Lond)       Date:  2017-01-13       Impact factor: 3.775

Review 2.  Advances in bone marrow stem cell therapy for retinal dysfunction.

Authors:  Susanna S Park; Elad Moisseiev; Gerhard Bauer; Johnathon D Anderson; Maria B Grant; Azhar Zam; Robert J Zawadzki; John S Werner; Jan A Nolta
Journal:  Prog Retin Eye Res       Date:  2016-10-23       Impact factor: 21.198

3.  Stem Cell Ophthalmology Treatment Study (SCOTS): bone marrow derived stem cells in the treatment of Dominant Optic Atrophy.

Authors:  Jeffrey N Weiss; Steven Levy
Journal:  Stem Cell Investig       Date:  2019-12-05

Review 4.  Extracellular vesicle therapy for retinal diseases.

Authors:  Ben Mead; Stanislav Tomarev
Journal:  Prog Retin Eye Res       Date:  2020-03-10       Impact factor: 19.704

Review 5.  Neuroprotection in glaucoma.

Authors:  C R Vishwaraj; Srinivasan Kavitha; Rengaraj Venkatesh; Aakriti Garg Shukla; Premanand Chandran; Shweta Tripathi
Journal:  Indian J Ophthalmol       Date:  2022-02       Impact factor: 2.969

6.  Human umbilical cord mesenchymal stem cell-derived exosomal miR-27b attenuates subretinal fibrosis via suppressing epithelial-mesenchymal transition by targeting HOXC6.

Authors:  Dongli Li; Junxiu Zhang; Zijia Liu; Yuanyuan Gong; Zhi Zheng
Journal:  Stem Cell Res Ther       Date:  2021-01-07       Impact factor: 6.832

Review 7.  Therapeutic effects of mesenchymal stem cells-derived extracellular vesicles' miRNAs on retinal regeneration: a review.

Authors:  Ali Rajool Dezfuly; Azadeh Safaee; Hossein Salehi
Journal:  Stem Cell Res Ther       Date:  2021-10-07       Impact factor: 6.832

8.  Stem Cell Ophthalmology Treatment Study: bone marrow derived stem cells in the treatment of non-arteritic ischemic optic neuropathy (NAION).

Authors:  Jeffrey N Weiss; Steven Levy; Susan C Benes
Journal:  Stem Cell Investig       Date:  2017-11-23

9.  Stem Cell Ophthalmology Treatment Study: bone marrow derived stem cells in the treatment of Retinitis Pigmentosa.

Authors:  Jeffrey N Weiss; Steven Levy
Journal:  Stem Cell Investig       Date:  2018-06-06

Review 10.  Extraocular, periocular, and intraocular routes for sustained drug delivery for glaucoma.

Authors:  Uday B Kompella; Rachel R Hartman; Madhoosudan A Patil
Journal:  Prog Retin Eye Res       Date:  2020-09-04       Impact factor: 21.198

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.